Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 114

1.

Does ALR deficiency pave the way for NASH progression?

Weiss TS, Melter M, Dayoub R.

Hepatology. 2020 Mar 29. doi: 10.1002/hep.31248. [Epub ahead of print]

PMID:
32222994
2.

Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver.

Buniatian GH, Weiskirchen R, Weiss TS, Schwinghammer U, Fritz M, Seferyan T, Proksch B, Glaser M, Lourhmati A, Buadze M, Borkham-Kamphorst E, Gaunitz F, Gleiter CH, Lang T, Schaeffeler E, Tremmel R, Cynis H, Frey WH 2nd, Gebhardt R, Friedman SL, Mikulits W, Schwab M, Danielyan L.

Cells. 2020 Feb 17;9(2). pii: E452. doi: 10.3390/cells9020452.

3.

Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients.

Feder S, Haberl EM, Spirk M, Weiss TS, Wiest R, Buechler C.

Clin Exp Med. 2020 Feb 20. doi: 10.1007/s10238-020-00617-4. [Epub ahead of print]

PMID:
32078718
4.

TGF-β2 silencing to target biliary-derived liver diseases.

Dropmann A, Dooley S, Dewidar B, Hammad S, Dediulia T, Werle J, Hartwig V, Ghafoory S, Woelfl S, Korhonen H, Janicot M, Wosikowski K, Itzel T, Teufel A, Schuppan D, Stojanovic A, Cerwenka A, Nittka S, Piiper A, Gaiser T, Beraza N, Milkiewicz M, Milkiewicz P, Brain JG, Jones DEJ, Weiss TS, Zanger UM, Ebert M, Meindl-Beinker NM.

Gut. 2020 Jan 28. pii: gutjnl-2019-319091. doi: 10.1136/gutjnl-2019-319091. [Epub ahead of print]

5.

Inflammation-associated suppression of metabolic gene networks in acute and chronic liver disease.

Campos G, Schmidt-Heck W, De Smedt J, Widera A, Ghallab A, Pütter L, González D, Edlund K, Cadenas C, Marchan R, Guthke R, Verfaillie C, Hetz C, Sachinidis A, Braeuning A, Schwarz M, Weiß TS, Banhart BK, Hoek J, Vadigepalli R, Willy J, Stevens JL, Hay DC, Hengstler JG, Godoy P.

Arch Toxicol. 2020 Jan;94(1):205-217. doi: 10.1007/s00204-019-02630-3. Epub 2020 Jan 9.

PMID:
31919559
6.

Serum Adiponectin Levels Do Not Distinguish Primary from Metastatic Liver Tumors.

Feder S, Kandulski A, Schacherer D, Weiss TS, Buechler C.

Anticancer Res. 2020 Jan;40(1):143-151. doi: 10.21873/anticanres.13935.

PMID:
31892562
7.

Augmenter of Liver Regeneration Reduces Ischemia Reperfusion Injury by Less Chemokine Expression, Gr-1 Infiltration and Oxidative Stress.

Weiss TS, Lupke M, Dayoub R, Geissler EK, Schlitt HJ, Melter M, Eggenhofer E.

Cells. 2019 Nov 12;8(11). pii: E1421. doi: 10.3390/cells8111421.

8.

Increased Expression of RUNX1 in Liver Correlates with NASH Activity Score in Patients with Non-Alcoholic Steatohepatitis (NASH).

Kaur S, Rawal P, Siddiqui H, Rohilla S, Sharma S, Tripathi DM, Baweja S, Hassan M, Vlaic S, Guthke R, Thomas M, Dayoub R, Bihari C, Sarin SK, Weiss TS.

Cells. 2019 Oct 18;8(10). pii: E1277. doi: 10.3390/cells8101277.

9.

Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma.

Feder S, Kandulski A, Schacherer D, Weiss TS, Buechler C.

Int J Mol Sci. 2019 Aug 12;20(16). pii: E3919. doi: 10.3390/ijms20163919.

10.

Perilipin 5 and Lipocalin 2 Expression in Hepatocellular Carcinoma.

Asimakopoulou A, Vucur M, Luedde T, Schneiders S, Kalampoka S, Weiss TS, Weiskirchen R.

Cancers (Basel). 2019 Mar 19;11(3). pii: E385. doi: 10.3390/cancers11030385.

11.

Augmenter of liver regeneration: Essential for growth and beyond.

Ibrahim S, Weiss TS.

Cytokine Growth Factor Rev. 2019 Feb;45:65-80. doi: 10.1016/j.cytogfr.2018.12.003. Epub 2018 Dec 16. Review.

12.

Bile acid-induced apoptosis and bile acid synthesis are reduced by over-expression of Augmenter of Liver Regeneration (ALR) in a STAT3-dependent mechanism.

Ibrahim S, Dayoub R, Krautbauer S, Liebisch G, Wege AK, Melter M, Weiss TS.

Exp Cell Res. 2019 Jan 1;374(1):189-197. doi: 10.1016/j.yexcr.2018.11.023. Epub 2018 Nov 28.

PMID:
30500391
13.

Bile acids down-regulate the expression of Augmenter of Liver Regeneration (ALR) via SHP/HNF4α1 and independent of Egr-1.

Ibrahim S, Dayoub R, Melter M, Weiss TS.

Exp Mol Pathol. 2018 Dec;105(3):236-242. doi: 10.1016/j.yexmp.2018.09.004. Epub 2018 Sep 20.

PMID:
30243934
14.

β-Defensin 1 Is Prominent in the Liver and Induced During Cholestasis by Bilirubin and Bile Acids via Farnesoid X Receptor and Constitutive Androstane Receptor.

Klag T, Thomas M, Ehmann D, Courth L, Mailänder-Sanchez D, Weiss TS, Dayoub R, Abshagen K, Vollmar B, Thasler WE, Stange EF, Berg CP, Malek NP, Zanger UM, Wehkamp J.

Front Immunol. 2018 Jul 27;9:1735. doi: 10.3389/fimmu.2018.01735. eCollection 2018.

15.

The adaptor protein alpha-syntrophin is reduced in human non-alcoholic steatohepatitis but is unchanged in hepatocellular carcinoma.

Rein-Fischboeck L, Pohl R, Haberl EM, Weiss TS, Buechler C.

Exp Mol Pathol. 2017 Oct;103(2):204-209. doi: 10.1016/j.yexmp.2017.09.005. Epub 2017 Sep 21.

PMID:
28941732
16.

Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.

Weiss TS, Lupke M, Ibrahim S, Buechler C, Lorenz J, Ruemmele P, Hofmann U, Melter M, Dayoub R.

PLoS One. 2017 Sep 6;12(9):e0184282. doi: 10.1371/journal.pone.0184282. eCollection 2017.

17.

Diagnostic Value of Systemic Cholesteryl Ester/Free Cholesterol Ratio in Hepatocellular Carcinoma.

Krautbauer S, Weiss TS, Wiest R, Schacherer D, Liebisch G, Buechler C.

Anticancer Res. 2017 Jul;37(7):3527-3535.

PMID:
28668842
18.

Chemokine (CC-motif) receptor-like 2 mRNA is expressed in hepatic stellate cells and is positively associated with characteristics of non-alcoholic steatohepatitis in mice and men.

Zimny S, Pohl R, Rein-Fischboeck L, Haberl EM, Krautbauer S, Weiss TS, Buechler C.

Exp Mol Pathol. 2017 Aug;103(1):1-8. doi: 10.1016/j.yexmp.2017.06.001. Epub 2017 Jun 15.

PMID:
28600126
19.

Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.

Dengler M, Staufer K, Huber H, Stauber R, Bantel H, Weiss KH, Starlinger P, Pock H, Klöters-Plachky P, Gotthardt DN, Rauch P, Lackner C, Stift J, Brostjan C, Gruenberger T, Kumada T, Toyoda H, Tada T, Weiss TS, Trauner M, Mikulits W.

Oncotarget. 2017 Jul 11;8(28):46234-46248. doi: 10.18632/oncotarget.17598.

20.

Augmenter of liver regeneration (ALR) exhibits a dual signaling impact on hepatic acute-phase response.

Dayoub R, Buerger L, Ibrahim S, Melter M, Weiss TS.

Exp Mol Pathol. 2017 Jun;102(3):428-433. doi: 10.1016/j.yexmp.2017.05.011. Epub 2017 May 12.

PMID:
28506765

Supplemental Content

Loading ...
Support Center